One-pot cascade reactions using fructose-6-phosphate aldolase: Efficient synthesis of D-arabinose 5-phosphate, D-fructose 6-phosphate and analogues by Sánchez-Moreno, Israel et al.
 1 
 COMMUNICATION 
DOI: 10.1002/adsc.200((will be filled in by the editorial staff)) 
One-pot Cascade Reactions using Fructose-6-phosphate 
Aldolase: Efficient Synthesis of D-Arabinose-5-phosphate, D-
Fructose-6-phosphate and Analogues 
Israel Sánchez-Moreno,a,b Virgil Hélaine,a,b Nicolas Poupart,a,b Franck Charmantray,a,b 
Bertrand Légeret,a,b Laurence Hecquet,a,b Eduardo García-Junceda,c Roland 
Wohlgemuth,d Christine Guérard-Hélainea,b* and Marielle Lemairea,b* 
a   Clermont Université, Université Blaise Pascal, Laboratoire SEESIB, BP 10448, F-63000 Clermont-Ferrand, France  
b CNRS, UMR 6504, SEESIB, F-63177 Aubière, France. 
Fax: 33473407717; christine.helaine@univ-bpclermont.fr; marielle.lemaire@univ-bpclermont.fr  
c Departamento de Química Bioorgánica, Instituto de Química Orgánica General, CSIC (IQOG-CSIC), Madrid 28006, 
Spain. 
d Sigma-Aldrich, Research Specialties, CH-9470 Buchs, Switzerland 
Received: ((will be filled in by the editorial staff)) 
Supporting information for this article is available on the WWW under http://dx.doi.org/10.1002/adsc.200###### 
Abstract. One-pot multienzymatic reactions have been 
performed for the synthesis of 1-deoxy-D-fructose-6-
phosphate, 1,2-dideoxy-D-arabino-hept-3-ulose-7-phos-
phate, D-fructose-6-phosphate and D-arabinose-5-
phosphate. The whole strategy is based on a fructose-6-
phosphate aldolase (FSA) mediated aldol key step as a part 
of three or four enzymes-catalysed cascade reactions. The 
four known donors for FSA dihydroxyacetone (DHA), 
hydroxy acetone (HA), 1-hydroxy-2-butanone (HB) and 
glycolaldehyde (GA) were used with D-glyceraldehyde-3-
phosphate as the acceptor substrate. The target 
phosphorylated sugars were obtained in good to excellent 
yields and high purity.  
Keywords: D-arabinose-5-phosphate; D-fructose-6-
phosphate; phosphorylated sugars; Fructose-6-phosphate 
aldolase; cascade reactions  
 
Phosphate esters are well established to play a 
dominant role in the physiology of cells and hence 
are essential to any organism. They provide the 
extremely stable backbone for the biopolymers that 
encode the genetic information (RNA then DNA) and 
on the other hand, they play an important role for 
protein regulation that is largely under the control of 
kinases and phosphatases. They are also involved in 
the generation, distribution, and application of free 
energy throughout the cell by using anhydrides of 
phosphoric acid and its esters, notably adenosine 
triphosphate.[1]-[3] Thus, phosphate groups are found 
in a wide variety of structurally diverse natural and 
biologically active molecules such as phospholipids, 
nucleic acids, nucleotides, proteins, coenzymes, 
steroids and in particular carbohydrates. Selectively 
phosphorylated chiral sugars are of importance as 
central metabolites in the non-oxidative pentose 
phosphate pathway, in the Calvin cycle and of 
particular interest for the study of various metabolic 
diseases.[4] Given the vital roles for such compounds 
many methods have been developed for their 
synthesis. Enzymatic methods ensure mild reaction 
conditions and furthermore, tedious protection and 
deprotection of functional groups often resulting in 
low yields can be circumvented.[5] For the preparative 
synthesis of monophosphorylated sugars two 
approaches are mainly found in the literature 
depending on the enzymes used: (i) by selective 
phosphorylation of an alcohol function and (ii) by C-
C bond formation. The first method is usually 
completed through the use of kinases albeit they often 
display narrow substrate specificity. Kinases require 
ATP as phosphoryl donor which generally needs to 
be regenerated in situ for two main reasons: (i) the 
resulting ADP is usually a strong inhibitor of the 
kinase and (ii) for use in large scale applications.[6] 
As an example, D-arabinose-5-phosphate, an 
important metabolite involved in the biosynthetic 
pathway of the outer membrane component 
lipopolysaccharide (LPS), was prepared via a kinase 
catalysed reaction.[7] Direct phosphorylation of a 
hydroxyl group using phosphatases or 
phosphotransferases and inorganic pyrophosphate 
have also been described by Wever et al.[5] In such 
process the key intermediate in the mechanism is an 
activated phosphorylated enzyme intermediate that 
may react with a nucleophile like for example 
primary alcohol function to yield a phosphorylated 
product. Water being a competitive nucleophile, the 
intermediate may also be hydrolysed, resulting in 
formation of free phosphate. In addition, the main 
drawback of such methodology relies on the 
reversibility of these phosphatase catalysed reactions 
causing dephosphorylation of the newly formed 
product. Thus reaction progress must be carefully 
monitored for quantitative production of the desired 
phosphorylated compound. However efficient 
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applications were illustrated in the preparative 
synthesis of glucose-6-phosphate[5a] and 
dihydroxyacetone phosphate (DHAP).[5b-c] Another 
alternative is the use of C-C bond formation catalysed 
by transketolase[4] alone, combined in cascade 
reaction with an aldolase[8] or catalysed by an 
aldolase in cascade reaction.[8c] Thus, efficient multi-
enzymatic syntheses of D-xylulose-5-phosphate were 
achieved.[4a],[8b] From the pioneer Fessner’s work, non 
natural 1-phosphate ketoses were synthesised in an 
artificial metabolic reaction cascade involving in situ 
formation of DHAP.[8a] Numerous methods based on 
enzymatic reaction cascades were described for the 
preparation of DHAP, as well as chemical 
methods.[8c,9] Recently, two thermophilic aldolases 
(D-fructose-1,6-bisphosphate aldolase (FBA) and 
deoxyribose aldolase (DERA)) were combined in 
vivo (E. coli) for the synthesis of deoxyribose-5-
phosphate in an artificial biosynthetic pathway.[10] 
Also synthases such as D-deoxyxylulose-5-phosphate 
synthase (DXP synthase)[4h],[11] or D-3-deoxy-D-
arabino-heptulosonate-7-phosphate synthase (DAHP 
synthase)[4h,i],[6] were used for the preparation of DXP 
and DAHP respectively. 
Fructose-6-phosphate aldolase (FSA) has been 
established over the last few years as a robust and 
powerful biocatalyst for stereoselective C-C bond 
formation.[12] Thus several efficient syntheses of 
sugars and analogues were readily described.[12c,13] 
Nevertheless using FSA as biocatalyst, no synthesis 
of phosphorylated sugars has been described in the 
literature to date.  
Cascade enzymatic pathways, which allow multi-
step conversions to take place in one reaction vessel, 
are crucial for the development of highly efficient 
new methods of chemo-enzymatic synthesis.[8],[14] 
Inspired by natural cascade procedures, we explored 
two straightforward multi-enzymatic strategies for the 
synthesis of several sugar monophosphates 
summarised in Figure 1. In the first one, all the 
substrates were achirals. Thus the chirality was 
elegantly introduced by biocatalysed asymmetric 
synthesis using two enzymes, an isomerase fixing one 
stereogenic center and an aldolase establishing two 
contiguous centers.  
 
 
Figure 1: Enzymatic cascade reactions. 
In the second one, the asymmetric centers were 
governed by two aldolases, combined in a 
multienzymatic process. Like in the biomimetic 
pathway described by Ohtake and coll.,[10] a 
dihydroxyacetone phosphate (DHAP) dependent 
aldolase was associated in tandem with a non-
phosphorylated donor dependent one. 
The first strategy (pathway A, Scheme 1) consisted in 
a one-pot two-steps reaction starting from 
dihydroxyacetone (DHA) in the presence of a 
cocktail of four biocatalysts. FSA acceptor substrate 
D-glyceraldehyde-3-phosphate (D-G3P) was obtained 
in situ by isomerisation of DHAP using 
triosephosphate isomerase (TPI). Interestingly, 
DHAP was readily synthesised from DHA by direct 
phosphorylation catalysed by dihydroxyacetone 
kinase[15] (DHAK) with ATP regenerated in situ by 
the phosphoenolpyruvate (PEP)/pyruvate kinase (PK) 
system. 
The second strategy (pathway B, Scheme 1) differed 
from the first one by means of D-G3P formation and 
corresponded to a one-pot one-step reaction. In this 
case, the acceptor aldehyde and DHAP were 
generated in situ from the split of D-fructose-1,6-
bisphosphate (FBP) catalysed by FBA . 
 
 
Scheme 1: Enzymatic cascade reactions using fructose-6-
phosphate aldolase (FSA) with in situ generated D-
glyceraldehyde-3-phosphate as the acceptor substrate. 
 3 
Hence, one-pot multienzymatic reactions (pathway A 
or B) have been set up for hundred mg scale synthesis 
of 1-deoxy-D-fructose-6-phosphate (1), 1,2-dideoxy-
D-arabino-hept-3-ulose-7-phosphate (2), D-fructose-
6-phosphate (3: D-F6P) and D-arabinose-5-phosphate 
(4: D-A5P) respectively from hydroxyacetone (HA), 
hydroxybutanone (HB), dihydroxyacetone (DHA) 
and glycolaldehyde (GA) as donors. Reaction with 
GA was not considered following pathway B. Indeed, 
GA was reported to be a good acceptor substrate for 
FBA that would lead to the formation of D-xylulose-
1-phosphate[16] as by-product. 
 
As the common substrate for each target compound 
was D-G3P, we first started with the study of FSA in 
the presence of this enantiopure aldehyde. The best 
acceptor substrate of FSA reported to date was the 
racemic D,L-G3P as indicated by the following 
kinetic parameters: KM=0.80 mM; kcat=173 s-1, 
kcat/KM=216s-1.mM-1).[13a] Those measured in this 
work for D-G3P were found relatively close to the 
above cited: KM=0.56 mM; kcat=195 s-1, kcat/KM=348 s-
1.mM-1. The FSA catalytic efficiency (kcat/KM) is 
slightly higher for D-G3P than for the racemic 
substrate. 
This aldehyde is known to be quite unstable under 
different conditions of pH and temperature.[4a-d],[10] 
Thus, for optimal reaction conditions determination 
for the one-pot multi-enzymatic system, stability of 
D,L-G3P was tested (see supplementary materials). 
As the results have shown that glycylglycine buffer 
usually employed for FSA over-expression [12] was 
really unsuitable, it was displaced in the FSA 
preparation by water through gel filtration. FSA in 
water displayed a good stability at 4ºC, retaining 
close to 100% of its initial activity after 1 month. 
Finally, TRIS-HCl buffer, which is known to be 
compatible with all the enzymes involved, was 
chosen for the cascade enzymatic reactions. 
 
We have then focused our work on the formation of 
D-G3P at a corresponding hundred mg scale. 
Chemical syntheses are tedious, giving low yields[17] 
or requiring laborious purification steps.[10],[18] 
Consequently, we decided to investigate described 
enzymatic routes. Two methods were selected: (i) one 
published by Whitesides[19] where DHAP[8c,9] was 
isomerised to D-G3P using TPI (pathway A) and (ii) 
using FBP as starting material and the sequential 
action of FBA and TPI (pathway B).[8],[10],[20] Initially, 
we have chosen to optimize the one-pot two-steps 
strategy (pathway A) based on DHAP accumulation 
before its transformation into D-G3P. In fact, the 
reaction parameters were controlled more easily as 
these two steps were independent. The equilibrium of 
the isomerisation reaction is in favour of DHAP 
(96%),[21] thus the formation of D-G3P had to be 
directly coupled with the FSA catalysed aldol 
reaction in order to obtain the best yields. 
 
Pathway A: 
Despite the fact that in our lab we were used to 
produce DHAP chemically or enzymatically,[21] the 
protocol described by García-Junceda’s group using 
DHAK for enzymatic phosphorylation of DHA was 
chosen for its ease of handling and final high yield 
and purity of DHAP.[15] Nevertheless, the 
regeneration of ATP based on acetate kinase, was 
changed and replaced for the phosphoenolpyruvate 
(PEP)/pyruvate kinase (PK) system. This latter 
system displays two interesting advantages for large 
scale biosynthesis of DHAP: (i) PEP is a more stable 
phosphate donor than the originally used 
acetylphosphate, and (ii) PK is a cheaper enzyme 
than acetate kinase. Applying the best determined 
1.0/0.8 DHA/PEP substrate ratio (see supplementary 
materials), DHAP could be synthesised in 95% yield, 
corresponding to a 1.4 g scale. Thus, a one-pot two-
steps reaction was carried out where DHAP was 
accumulated prior to the addition of TPI and FSA in 
order to complete DHA consumption. Indeed, a one-
pot one-step reaction was not considered to avoid 
FSA catalysed DHA conversion, as a side reaction. 
For each FSA donor substrate, the time course of 
the aldolisation reaction was spectrophotometrically 
monitored by either following monosaccharide 
appearance or DHAP disappearance, using GPDH 
(-glycerophosphate dehydrogenase)/TPI NADH 
dependent assay with or without FSA respectively 
(see supplementary materials). 
By initially adding three equivalents of the donor 
substrate, equilibrium was rapidly reached in favour 
of the desired sugar. Indeed, a mixture of mono-
saccharide/DHAP (ratio from 90/10 to 95/5) was 
obtained and confirmed by NMR spectroscopy, 
depending on the donor used. To completely shift this 
equilibrium, we decided to increase the quantity of 
donor by portion wise addition. Thereby, after adding 
a total amount of 6 to 12 equivalents depending on 
the donor substrate, no DHAP could be detected by 
both the spectrophotometric assay and the NMR 
spectra analysis, revealing a DHAP total conversion 
(see supplementary materials). 
Then, we performed the reactions at a hundred mg 
scale varying the donor substrate but using the same 
quantity (w/w) of FSA (13U) or FSA A129S 
(optimised for DHA donor substrate: 50U).[12b] For 
completion, the reactions were run for 30 minutes or 
1.5 h (Figure 2, pathway A). HB being the worst 
donor substrate as shown in figure 2, the reaction with 
this donor was slower than in the presence of other 
donors. When assaying for sugar concentration by 
retroaldolisation, 100% analytical yield was reached 
for the phosphorylated sugar formed, except when 
GA was used as donor where only traces or no D-A5P 
could be detected. This result could be due to the 
large excess of GA used, as mentioned above. When 
using 9 equivalents of GA, FSA has also catalysed 
GA self-addition to give D-threose as by-product. As 
this compound was known to have a slightly higher 
affinity for FSA (KM=0.3 mM) compared to D-A5P 
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(KM=0.56 mM),[13a] probably a competition in favour 
of D-threose (present in higher concentration than 
Ara-5-P) could occur in the active site, hampering the 
retroaldolisation of D-A5P, which disturbs the assay. 
 
 
 
Figure 2. FSA mediated reaction progresses with the four 
tested donors and either DHAP (above, pathway A) or FBP 
(below, pathway B) as the source of D-G3P acceptor 
substrate. For method A, DHAP disappearance was 
monitored using a spectrophotometric GPDH/TPI assay 
while for method B, FBP disappearance was monitored 
using a spectrophotometric FBA/GPDH/TPI assay. 
Pathway B: 
Following the same set of conditions for pathway 
A, i.e. using 3 to 12 equivalents of donor substrate, 
reactions were carried out from FBP as the source of 
D-G3P and using FBA, TPI and FSA concomitantly. 
Reaction progress was monitored by assaying FBP 
upon time using a discontinuous spectrophotometric 
assay with FBA, GPDH and TPI. For the 3 reactions 
tested with HA, HB and DHA (Figure 2, pathway B), 
FBP consumption reached 95, 90 and 95% 
respectively after 90, 120 and 60 minutes respectively. 
Again, HB revealed to be the worst donor substrate of 
the three tested. Reaction times were lower in 
pathway A than in pathway B because in the former 
DHAP is directly converted to D-G3P by mean of TPI, 
whereas in the latter the FBP retroaldolisation 
catalysed by FBA is required before the isomerisation 
step. Despite HB was not fully converted, compound 
2 was not contaminated by FBP as attested by NMR 
spectra. We would propose that a sequential barium 
phosphate precipitation would have occurred due to 
structurally different phosphate groups.  
The results from both methods are summarised in 
table 1. Four phosphorylated monosaccharides were 
thus obtained in good to excellent yields. Simple 
precipitation of the monosaccharides, directly from 
the reaction mixture as barium salts, has led to high 
organic purity as depicted by the NMR spectra 
available in the supplementary information. Purity of 
salts determined spectrophotometrically in a 
retroaldol process by assaying D-G3P was found 
above at least 90%. The new sugars, 1-deoxy-D-
fructose-6-phosphate 1 and 1,2-dideoxy-D-arabino-
hept-3-ulose-7-phosphate 2 were fully characterised 
for the first time. 1H as well as 13C NMR spectra 
analysis revealed the number and proportion of the 
different forms existing in acidic water. Concerning 
D-F6P and D-A5P, we have found close values of 
chemical shifts than those from the literature.[22-23] It’s 
noteworthy that the percentages of the  form 
decreased with the steric hindrance on the anomeric 
carbon, the bulky groups like ethyl or hydroxymethyl 
being preferably found in equatorial positions.  
Table 1. Yields and structural forms of the 
monosaccharides phosphates in acidic aqueous solution 
(pH=1). 
sugar 
Yield (%) Composition (%) 
A B   linear 
1 95 75 43 23 34 
2 94 65 42 12 46 
3 80 65 81(82[22])a 19(16[22])a 0(2.2[22]) a 
4 87 n.a 41(40[23])a 59(58[23])a 0(2[23]) a 
a) values in brackets are reported data 
 
 In conclusion, a new type of enzymatic one pot 
cascade reaction has been successfully designed, 
developed and applied to the preparation of four 
phosphorylated sugars of high biological interest. 
Compounds 1 and 2 have been reported for the first 
time in this work. A single precipitation step directly 
from the reaction mixture afforded the target 
compounds 1-4 as their barium salts in high yields 
and purities. The two methodologies described herein 
are complementary. On one hand, pathway A gives 
access to all target phosphorylated monosaccharides 
in very good yields but using an ATP regenerating 
system. On the other hand, pathway B, revealed to be 
an interesting alternative route, except for the D-A5P 
synthesis, for its ease of handling and by the 
commercial availability of FBA. As we could extend 
these two methods to other substrates and other 
reactions catalysed by FSA, we believe that this work 
represents a consequent improvement in enzymatic 
synthesis of important metabolites and their 
analogues. Other phosphorylated monosaccharides 
would be accessible using higher or lower 
homologous acceptor substrates such as 
glycolaldehyde phosphate, currently under 
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investigation in our lab. The further exploration of the 
synthetic methodology towards selectively phospho-
rylated and differentially functionalised mono-
saccharides is not only of interest for central 
metabolites, but also for remote metabolites having 
important biological functions. [25] 
Experimental Section 
Pathway A: the one-pot two-steps reaction were carried 
out in TRIS-HCl buffer (20 mL, 40 mM, pH 7.5) 
containing DHA (0.8 mmol), phosphoenol pyruvate (0.64 
mmol), MgSO4 (10 mM), DHAK (11 U) and PK (14 U). 
The reactions were initiated upon addition of ATP (52 
mol). When DHAP accumulation was closed to 95%, 3 
eq of donor were added and pH was adjusted to 8.0 with 
NaOH 1M. 13 U of FSA wt[12a] (or 50 U FSA A129S[12b] 
when DHA was used as the donor substrate) and 400 U of 
TPI were finally added. The reaction proceeded at room 
temperature under gentle agitation (100-200 rpm). The 
reactions were run for about one hour and more. Every 25 
min, 3 eq of donor were added (HA: a total of 9 eq, 55 min 
reaction time; HB: a total of 12 eq, one hour and a half 
reaction time; DHA a total of 6 eq, 30 minutes and GA: a 
total of 9 eq, 70 min reaction time).  
Pathway B: Fructose-1,6-bisphosphate (0.33 mmol) was 
placed with FBA from rabbit muscle (250 U), and TPI 
(1000 U), in TRIS HCl buffer (pH 8.0, 40 mM, 25 mL). 
Then 6 eq of donor (2 mmol) were added. Once the 
solution homogenised, the reaction was initiated with 34 
units of FSA wt (100 U of FSA A129S with DHA as the 
donor). The reaction proceeded at room temperature under 
gentle agitation (100-200 rpm). Every 25 min 6 more eq of 
donor were added (HA, 18 eq, 90 min of reaction; HB, 24 
eq, 120 min of reaction; DHA 12 eq, 60 min of reaction).  
General purification protocol: The reactions were 
stopped by dropping the pH to 3.0 resulting in partial 
precipitation of the enzymes. The pH was then adjusted to 
6.0 and 2 eq of BaCl2, 6H2O were added. The solutions 
were centrifuged 10 min at 10,000 rpm at 4°C and the 
pellets were discarded. After partial concentration in vacuo, 
5 volumes of ethanol were added. The solutions were let 
overnight at 4°C and then centrifuged. The sugar barium 
salts were obtained as white powders after one washing 
with ethanol followed by two other washings with acetone.  
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